Literature DB >> 14630302

The Maudsley Early-Onset Schizophrenia Study: cognitive function in adolescent-onset schizophrenia.

Eugenia Kravariti1, Robin G Morris, Sophia Rabe-Hesketh, Robin M Murray, Sophia Frangou.   

Abstract

The neuropsychological correlates of adolescent-onset schizophrenia have been investigated very little to date. We assessed intelligence, memory and executive function in 42 patients with adolescent-onset schizophrenia and 43 healthy control subjects. Cases showed impairments in most cognitive variables. Despite the overall similarity with the quantitative and qualitative performance characteristics of later-onset patients in the literature, their cognitive profile displayed a unique feature: modification of the usual pattern of thinking latencies in the Tower of London Task. After adjusting for potential confounders, no effect of illness duration, symptoms or medication dose on patient performance emerged. However, longer exposure to medication predicted a lower level of performance in aspects of attention, psychomotor processing speed and spatial working memory. Our data are not consistent with worse cognition or progression of neuropsychological impairment in adolescent-onset schizophrenia.

Entities:  

Mesh:

Year:  2003        PMID: 14630302     DOI: 10.1016/s0920-9964(03)00067-7

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  18 in total

1.  The Maudsley early onset schizophrenia study. Predictors of psychosocial outcome at 4-year follow-up.

Authors:  Nora S Vyas; Michael Hadjulis; Apostolos Vourdas; Patrick Byrne; Sophia Frangou
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-10       Impact factor: 4.785

2.  Neuropsychological profile in early-onset schizophrenia-spectrum disorders: measured with the MATRICS battery.

Authors:  Aina Holmén; Monica Juuhl-Langseth; Rune Thormodsen; Ingrid Melle; Bjørn Rishovd Rund
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

3.  Cognitive function in early onset schizophrenia: a selective review.

Authors:  Sophia Frangou
Journal:  Front Hum Neurosci       Date:  2010-01-29       Impact factor: 3.169

4.  Level and pattern of neuropsychological functioning in early-onset psychoses.

Authors:  D-M Walker; P J Standen
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-10-12       Impact factor: 4.785

5.  Lack of Gender-Related Differences in Childhood-Onset Schizophrenia.

Authors:  Anna E Ordóñez; Frances F Loeb; Xueping Zhou; Lorie Shora; Rebecca A Berman; Diane D Broadnax; Peter Gochman; Siyuan Liu; Judith L Rapoport
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-07-01       Impact factor: 8.829

6.  Serum glutamine, set-shifting ability and anorexia nervosa.

Authors:  Michiko Nakazato; Kenji Hashimoto; Ulrike Schmidt; Kate Tchanturia; Iain C Campbell; David A Collier; Masaomi Iyo; Janet Treasure
Journal:  Ann Gen Psychiatry       Date:  2010-06-25       Impact factor: 3.455

7.  Neuropsychological functioning in early-onset first-episode psychosis: comparison of diagnostic subgroups.

Authors:  Arantzazu Zabala; Marta Rapado; Celso Arango; Olalla Robles; Elena de la Serna; Cristina González; José Manuel Rodríguez-Sánchez; Patricia Andrés; María Mayoral; Igor Bombín
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-09-19       Impact factor: 5.270

8.  Examination of spatial working memory performance in children and adolescents with attention deficit hyperactivity disorder, combined type (ADHD-CT) and anxiety.

Authors:  Alasdair Vance; Maite Ferrin; Jo Winther; Rapson Gomez
Journal:  J Abnorm Child Psychol       Date:  2013-08

9.  The Maudsley early onset schizophrenia study: cognitive function over a 4-year follow-up period.

Authors:  Sophia Frangou; Michael Hadjulis; Apostolos Vourdas
Journal:  Schizophr Bull       Date:  2007-11-15       Impact factor: 9.306

10.  Cognitive correlates of schizophrenia signs and symptoms: I. Verbal communication disturbances.

Authors:  Howard Berenbaum; John G Kerns; Laura L Vernon; Jose J Gomez
Journal:  Psychiatry Res       Date:  2008-04-18       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.